Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Experimenting With New Pricing Models In Oncology

Jun 19 2013

Related Content

Roche’s Oncology Output Could Lead To Reimbursement Problems Down The Line

Jan 30 2013

Many New Oncology Drugs In 2012, With Prices That Test The Limits

Jan 28 2013

ASCO Data Support Roche’s Grand Plan For Non-Stop Avastin Treatment

Jun 11 2012

<em>Avastin </em>Takes One Step Forward, One Step Back At ASCO

Jun 03 2013

NICE Rejects Avastin For Ovarian Cancer On Cost, Okays Lucentis

May 22 2013

Related Companies

Roche Holding AG

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

Business Strategies Pricing Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window